Ultrarapid Vitrification of Snow Leopard (Panthera uncia) Fibroblasts

2026

Closed access Metadata (CSL-JSON)
DOI 10.30919/ee2558
Data confidence 85 high
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

Somatic cell biobanking supports conservation of endangered felids, yet cryopreservation protocols for the snow leopard (Panthera uncia) remain insufficiently standardised.We evaluated the effects of vitrification-solution composition and cooling procedure on post-thaw membrane integrity of dermal fibroblasts from 16 wild individuals.Cells were assigned to six treatments comprising 20% dimethyl sulphoxide (DMSO), 20% ethylene glycol (EG), or 20% DMSO + 20% EG, each with 0.5 M sucrose, combined with conventional cooling in liquid nitrogen (-196 °C) or VitMaster-assisted supercooled vitrification (-205 °C).Cryoprotectant composition strongly affected post-thaw membrane integrity (F2, 90 = 419.70,p < 0.0001, partial η 2 = 0.903).DMSO-EG yielded higher integrity (64.5 ± 0.6%) than DMSO (42.8 ± 0.6%) or EG (43.9 ± 0.6%; both p < 0.0001), whereas DMSO and EG did not differ (p = 0.397).Cooling procedure had no significant effect (F1, 90 = 2.87, p = 0.094, partial η 2 = 0.031), nor did its interaction with cryoprotectant composition (F2, 90 = 0.18, p = 0.837).All treatments reduced membrane integrity.DMSO-EG with conventional cooling yielded the highest integrity, whereas supercooling conferred no demonstrated benefit.Concentration-matched controls are needed to distinguish formulation from total cryoprotectant concentration effects.